Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01215461 · ClinicalTrials.gov registry record

Factors Associated With Mortality in Neonates

A clinical trial, sponsored by Pediatrix.

Completed
Registry status
645
Enrollment target

NCT01215461: Completed study, sponsored by Pediatrix.

NCT01215461 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 645 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01215461 has completed, sponsored by Pediatrix.

COMPLETED
Registry status
645 participants
Enrollment target

Study Summary

The purpose of this study is to better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. As a result, an improved neonatal mortality classification system may be defined.

Trial Details

FieldValue
Enrollment Target 645 participants
Start Date 2010-09
Est. Completion 2012-10
Pediatrix

28 total trials

What the finished NCT01215461 record still lists

NCT01215461 is an observational study that tracks outcomes without assigning an intervention. The registered 645 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01215461 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01215461 about?

NCT01215461 is a clinical study titled "Factors Associated With Mortality in Neonates". The purpose of this study is to better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. As a result, an improved neonatal mortality classification system may be defined.

What is the current status of trial NCT01215461?

This trial is currently completed. The enrollment target is 645 participants. The study started on 2010-09. Estimated completion is 2012-10.

Who is sponsoring clinical trial NCT01215461?

This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07012395 · 645 participants · Phase 2

    A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • NCT04863222 · 646 participants · Phase 4

    Clinical and Radiographic Success of MTA vs Biodentine

  • NCT05146297 · 644 participants · NA

    Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

  • NCT06994442 · 644 participants · Phase 3

    Optimizing Pain Treatment in Children On Mechanical Ventilation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01215461, the US trial registry maintained by the National Library of Medicine. NCT01215461 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.